Drug
Darolutamide
Important: Reactions below are the flagged terms from this drug’s
FAERS report history (min. 3 co-reports per term) — PRR/ROR indicate
disproportionality in spontaneous reporting, not causation.
Data from FDA FAERS via openFDA. Last recalculated: 2026-09-14.
| Reaction | Co-reports (a) | PRR | ROR | Signal | |
|---|---|---|---|---|---|
| 1 | Prostatic Specific Antigen Increased | 230 | 64.3 | 67.1 | signal |
| 2 | Metastases To Bone | 137 | 32.2 | 33.0 | signal |
| 3 | Hot Flush | 622 | 31.7 | 35.6 | signal |
| 4 | Brain Fog | 45 | 11.8 | 11.9 | signal |
| 5 | Nocturia | 32 | 10.1 | 10.1 | signal |
| 6 | Neuropathy Peripheral | 189 | 7.6 | 7.9 | signal |
| 7 | Product Dose Omission In Error | 52 | 7.4 | 7.5 | signal |
| 8 | Interstitial Lung Disease | 85 | 6.7 | 6.8 | signal |
| 9 | Prostate Cancer | 131 | 6.2 | 6.3 | signal |
| 10 | Muscle Atrophy | 20 | 6.1 | 6.1 | signal |
| 11 | Neutrophil Count Decreased | 63 | 5.9 | 6.0 | signal |
| 12 | Pollakiuria | 63 | 5.8 | 5.8 | signal |
| 13 | Myelosuppression | 50 | 5.6 | 5.7 | signal |
| 14 | Therapy Interrupted | 99 | 5.5 | 5.6 | signal |
| 15 | Metastases To Liver | 24 | 5.2 | 5.2 | signal |
| 16 | Taste Disorder | 27 | 5.1 | 5.2 | signal |
| 17 | Urinary Retention | 43 | 4.9 | 5.0 | signal |
| 18 | Blood Sodium Decreased | 24 | 4.9 | 4.9 | signal |
| 19 | Liver Function Test Increased | 27 | 4.8 | 4.8 | signal |
| 20 | Urosepsis | 11 | 4.6 | 4.6 | signal |
| 21 | Blood Calcium Decreased | 13 | 4.4 | 4.4 | signal |
| 22 | Night Sweats | 37 | 4.4 | 4.4 | signal |
| 23 | Red Blood Cell Count Decreased | 32 | 4.3 | 4.3 | signal |
| 24 | Fatigue | 829 | 4.1 | 4.6 | signal |
| 25 | Blood Urine Present | 20 | 4.0 | 4.0 | signal |
| 26 | Metastases To Lung | 12 | 4.0 | 4.0 | signal |
| 27 | Pneumonitis | 28 | 4.0 | 4.0 | signal |
| 28 | Bone Pain | 58 | 3.8 | 3.8 | signal |
| 29 | Libido Decreased | 12 | 3.7 | 3.7 | signal |
| 30 | Gait Inability | 32 | 3.7 | 3.7 | signal |
| 31 | Cytokine Release Syndrome | 18 | 3.6 | 3.6 | signal |
| 32 | Incontinence | 10 | 3.6 | 3.6 | signal |
| 33 | Dizziness Postural | 9 | 3.6 | 3.6 | signal |
| 34 | Febrile Neutropenia | 62 | 3.6 | 3.6 | signal |
| 35 | Asthenia | 352 | 3.6 | 3.7 | signal |
| 36 | Decreased Activity | 10 | 3.6 | 3.6 | signal |
| 37 | Blood Iron Decreased | 11 | 3.6 | 3.6 | signal |
| 38 | Incorrect Dose Administered | 208 | 3.5 | 3.6 | signal |
| 39 | Dysuria | 34 | 3.5 | 3.5 | signal |
| 40 | Bladder Disorder | 9 | 3.4 | 3.5 | signal |
| 41 | Pneumocystis Jirovecii Pneumonia | 9 | 3.4 | 3.4 | signal |
| 42 | Renal Impairment | 74 | 3.4 | 3.4 | signal |
| 43 | Ageusia | 22 | 3.4 | 3.4 | signal |
| 44 | Erectile Dysfunction | 22 | 3.3 | 3.3 | signal |
| 45 | Polyneuropathy | 10 | 3.2 | 3.2 | signal |
| 46 | Emotional Disorder | 26 | 3.2 | 3.2 | signal |
| 47 | Cytopenia | 10 | 3.2 | 3.2 | signal |
| 48 | Dementia | 22 | 3.0 | 3.0 | signal |
| 49 | Inappropriate Antidiuretic Hormone Secretion | 8 | 3.0 | 3.0 | signal |
| 50 | Blood Test Abnormal | 11 | 3.0 | 3.0 | signal |
| 51 | Product Use Complaint | 12 | 3.0 | 3.0 | signal |
| 52 | Hepatotoxicity | 17 | 2.9 | 2.9 | signal |
| 53 | Apathy | 11 | 2.9 | 2.9 | signal |
| 54 | Dysstasia | 22 | 2.9 | 2.9 | signal |
| 55 | Constipation | 162 | 2.9 | 2.9 | signal |
| 56 | Dyspnoea Exertional | 28 | 2.8 | 2.9 | signal |
| 57 | Hepatic Function Abnormal | 27 | 2.8 | 2.8 | signal |
| 58 | Blood Alkaline Phosphatase Increased | 18 | 2.8 | 2.8 | signal |
| 59 | Product Dose Omission Issue | 204 | 2.7 | 2.8 | signal |
| 60 | Alanine Aminotransferase Increased | 44 | 2.7 | 2.7 | signal |
| 61 | Hepatic Enzyme Increased | 48 | 2.7 | 2.7 | signal |
| 62 | Micturition Urgency | 8 | 2.7 | 2.7 | signal |
| 63 | Feeding Disorder | 14 | 2.7 | 2.7 | signal |
| 64 | Hypersomnia | 20 | 2.7 | 2.7 | signal |
| 65 | Renal Disorder | 32 | 2.6 | 2.6 | signal |
| 66 | Blood Potassium Increased | 11 | 2.6 | 2.6 | signal |
| 67 | Liver Disorder | 30 | 2.6 | 2.6 | signal |
| 68 | Myalgia | 115 | 2.6 | 2.6 | signal |
| 69 | Urinary Incontinence | 20 | 2.6 | 2.6 | signal |
| 70 | Rhabdomyolysis | 28 | 2.6 | 2.6 | signal |
| 71 | Full Blood Count Abnormal | 7 | 2.5 | 2.5 | signal |
| 72 | Glomerular Filtration Rate Decreased | 8 | 2.5 | 2.5 | signal |
| 73 | Aspartate Aminotransferase Increased | 35 | 2.5 | 2.5 | signal |
| 74 | Hepatic Cytolysis | 8 | 2.5 | 2.5 | signal |
| 75 | Bone Disorder | 12 | 2.5 | 2.5 | signal |
| 76 | Generalised Oedema | 8 | 2.5 | 2.5 | signal |
| 77 | Decreased Appetite | 150 | 2.5 | 2.5 | signal |
| 78 | Blood Creatinine Increased | 42 | 2.4 | 2.5 | signal |
| 79 | Mood Swings | 20 | 2.4 | 2.4 | signal |
| 80 | Knee Operation | 6 | 2.4 | 2.4 | no signal |
| 81 | Bedridden | 8 | 2.3 | 2.3 | signal |
| 82 | Disease Progression | 71 | 2.3 | 2.3 | signal |
| 83 | Spinal Pain | 7 | 2.3 | 2.3 | no signal |
| 84 | Blood Glucose Abnormal | 11 | 2.3 | 2.3 | signal |
| 85 | Sluggishness | 6 | 2.3 | 2.3 | no signal |
| 86 | Infusion Related Reaction | 39 | 2.3 | 2.3 | signal |
| 87 | Initial Insomnia | 6 | 2.2 | 2.2 | no signal |
| 88 | Peripheral Swelling | 90 | 2.2 | 2.3 | signal |
| 89 | Muscular Weakness | 66 | 2.2 | 2.2 | signal |
| 90 | Coronary Artery Occlusion | 8 | 2.2 | 2.2 | signal |
| 91 | Malignant Neoplasm Progression | 59 | 2.2 | 2.2 | signal |
| 92 | Spinal Operation | 7 | 2.2 | 2.2 | no signal |
| 93 | Mental Impairment | 14 | 2.2 | 2.2 | signal |
| 94 | Pain In Extremity | 170 | 2.2 | 2.2 | signal |
| 95 | Dysphagia | 54 | 2.2 | 2.2 | signal |
| 96 | Renal Pain | 6 | 2.2 | 2.2 | no signal |
| 97 | Pneumothorax | 9 | 2.2 | 2.2 | signal |
| 98 | Illness | 57 | 2.2 | 2.2 | signal |
| 99 | Arthralgia | 235 | 2.2 | 2.2 | signal |
| 100 | Eating Disorder | 12 | 2.1 | 2.1 | signal |
| 101 | Blood Bilirubin Increased | 15 | 2.1 | 2.1 | signal |
| 102 | Pelvic Pain | 10 | 2.1 | 2.1 | signal |
| 103 | Pulmonary Arterial Hypertension | 8 | 2.1 | 2.1 | no signal |
| 104 | Cardiac Disorder | 51 | 2.1 | 2.1 | signal |
| 105 | Nerve Compression | 5 | 2.1 | 2.1 | no signal |
| 106 | Product Prescribing Issue | 11 | 2.1 | 2.1 | signal |
| 107 | Haematotoxicity | 5 | 2.1 | 2.1 | no signal |
| 108 | Nerve Injury | 6 | 2.1 | 2.1 | no signal |
| 109 | Middle Insomnia | 10 | 2.0 | 2.1 | signal |
| 110 | Personality Change | 5 | 2.0 | 2.0 | no signal |
| 111 | Increased Appetite | 10 | 2.0 | 2.0 | signal |
| 112 | Arteriosclerosis | 5 | 2.0 | 2.0 | no signal |
| 113 | Musculoskeletal Discomfort | 9 | 2.0 | 2.0 | no signal |
| 114 | Pharyngeal Swelling | 5 | 2.0 | 2.0 | no signal |
| 115 | Lethargy | 30 | 2.0 | 2.0 | no signal |
| 116 | Feeling Hot | 32 | 2.0 | 2.0 | no signal |
| 117 | Hyperhidrosis | 67 | 2.0 | 2.0 | no signal |
| 118 | Therapy Change | 5 | 2.0 | 2.0 | no signal |
| 119 | Limb Discomfort | 16 | 2.0 | 2.0 | no signal |
| 120 | Limb Injury | 14 | 2.0 | 2.0 | no signal |
| 121 | Back Pain | 120 | 2.0 | 2.0 | no signal |
| 122 | Atrial Fibrillation | 50 | 2.0 | 2.0 | no signal |
| 123 | Death | 441 | 2.0 | 2.0 | no signal |
| 124 | Gynaecomastia | 16 | 1.9 | 2.0 | no signal |
| 125 | Blood Triglycerides Increased | 9 | 1.9 | 1.9 | no signal |
| 126 | Macular Degeneration | 6 | 1.9 | 1.9 | no signal |
| 127 | Balance Disorder | 43 | 1.9 | 1.9 | no signal |
| 128 | Full Blood Count Decreased | 10 | 1.9 | 1.9 | no signal |
| 129 | Weight Increased | 110 | 1.9 | 1.9 | no signal |
| 130 | Back Disorder | 8 | 1.9 | 1.9 | no signal |
| 131 | Angina Pectoris | 14 | 1.9 | 1.9 | no signal |
| 132 | Frequent Bowel Movements | 13 | 1.8 | 1.8 | no signal |
| 133 | Glycosylated Haemoglobin Increased | 12 | 1.8 | 1.8 | no signal |
| 134 | Transfusion | 5 | 1.8 | 1.8 | no signal |
| 135 | Fracture | 9 | 1.8 | 1.8 | no signal |
| 136 | Dizziness | 236 | 1.8 | 1.8 | no signal |
| 137 | Poor Quality Sleep | 10 | 1.8 | 1.8 | no signal |
| 138 | Haemoglobin Decreased | 48 | 1.8 | 1.8 | no signal |
| 139 | Feeling Cold | 13 | 1.8 | 1.8 | no signal |
| 140 | Faeces Discoloured | 10 | 1.8 | 1.8 | no signal |
| 141 | Pulmonary Thrombosis | 5 | 1.7 | 1.7 | no signal |
| 142 | Blood Pressure Abnormal | 9 | 1.7 | 1.7 | no signal |
| 143 | White Blood Cell Count Decreased | 49 | 1.7 | 1.7 | no signal |
| 144 | Gamma-glutamyltransferase Increased | 10 | 1.7 | 1.7 | no signal |
| 145 | Ejection Fraction Decreased | 7 | 1.7 | 1.7 | no signal |
| 146 | Thirst | 8 | 1.7 | 1.7 | no signal |
| 147 | Head Injury | 14 | 1.7 | 1.7 | no signal |
| 148 | Mood Altered | 12 | 1.7 | 1.7 | no signal |
| 149 | Neutropenia | 59 | 1.7 | 1.7 | no signal |
| 150 | Brain Neoplasm | 4 | 1.7 | 1.7 | no signal |
| 151 | Hepatic Failure | 13 | 1.6 | 1.6 | no signal |
| 152 | Spinal Disorder | 4 | 1.6 | 1.6 | no signal |
| 153 | Musculoskeletal Disorder | 8 | 1.6 | 1.6 | no signal |
| 154 | Blood Pressure Fluctuation | 10 | 1.6 | 1.6 | no signal |
| 155 | Memory Impairment | 57 | 1.6 | 1.6 | no signal |
| 156 | Laboratory Test Abnormal | 12 | 1.6 | 1.6 | no signal |
| 157 | Tooth Extraction | 5 | 1.5 | 1.5 | no signal |
| 158 | Spinal Fracture | 8 | 1.5 | 1.5 | no signal |
| 159 | Rash Papular | 9 | 1.5 | 1.5 | no signal |
| 160 | Brain Injury | 4 | 1.5 | 1.5 | no signal |
| 161 | Cold Sweat | 7 | 1.5 | 1.5 | no signal |
| 162 | Hospitalisation | 60 | 1.5 | 1.5 | no signal |
| 163 | Metastases To Central Nervous System | 5 | 1.5 | 1.5 | no signal |
| 164 | Palmar-plantar Erythrodysaesthesia Syndrome | 9 | 1.5 | 1.5 | no signal |
| 165 | Procedural Pain | 10 | 1.4 | 1.4 | no signal |
| 166 | Stevens-johnson Syndrome | 8 | 1.4 | 1.4 | no signal |
| 167 | Drug Effect Less Than Expected | 5 | 1.4 | 1.4 | no signal |
| 168 | Femur Fracture | 11 | 1.4 | 1.4 | no signal |
| 169 | Face Oedema | 6 | 1.3 | 1.4 | no signal |
| 170 | Cerebrovascular Accident | 59 | 1.3 | 1.3 | no signal |
| 171 | Hip Fracture | 11 | 1.3 | 1.3 | no signal |
| 172 | Diabetes Mellitus Inadequate Control | 6 | 1.3 | 1.3 | no signal |
| 173 | Accident | 4 | 1.3 | 1.3 | no signal |
| 174 | Tendon Rupture | 4 | 1.2 | 1.2 | no signal |
| 175 | Blood Glucose Increased | 61 | 1.2 | 1.2 | no signal |
| 176 | Eye Inflammation | 3 | 1.2 | 1.2 | no signal |
| 177 | Neoplasm Malignant | 21 | 1.2 | 1.2 | no signal |
| 178 | Surgery | 18 | 1.2 | 1.2 | no signal |
| 179 | Malignant Melanoma | 4 | 1.1 | 1.1 | no signal |
| 180 | Euphoric Mood | 3 | 1.1 | 1.1 | no signal |
| 181 | Dialysis | 4 | 1.1 | 1.1 | no signal |
| 182 | Dry Skin | 36 | 1.0 | 1.0 | no signal |
| 183 | Cardiovascular Disorder | 7 | 1.0 | 1.0 | no signal |
| 184 | Internal Haemorrhage | 3 | 1.0 | 1.0 | no signal |
| 185 | Sexual Dysfunction | 3 | 1.0 | 1.0 | no signal |
| 186 | Neoplasm Progression | 9 | 1.0 | 1.0 | no signal |
| 187 | Abnormal Dreams | 7 | 1.0 | 1.0 | no signal |
| 188 | Extra Dose Administered | 10 | 1.0 | 1.0 | no signal |
| 189 | Hepatic Cancer | 6 | 0.9 | 0.9 | no signal |
| 190 | Intercepted Product Preparation Error | 3 | 0.9 | 0.9 | no signal |
| 191 | Neurotoxicity | 4 | 0.9 | 0.9 | no signal |
| 192 | Product Availability Issue | 5 | 0.9 | 0.8 | no signal |
| 193 | Device Occlusion | 3 | 0.8 | 0.8 | no signal |
| 194 | Incorrect Product Administration Duration | 4 | 0.8 | 0.8 | no signal |
| 195 | Multiple Fractures | 3 | 0.7 | 0.7 | no signal |
| 196 | Pancreatic Carcinoma | 4 | 0.5 | 0.5 | no signal |
| 197 | Injection Site Rash | 4 | 0.5 | 0.5 | no signal |
| 198 | Gastric Cancer | 3 | 0.4 | 0.4 | no signal |
| 199 | Bladder Cancer | 5 | 0.3 | 0.3 | no signal |
| 200 | Device Leakage | 3 | 0.3 | 0.3 | no signal |